Sirolimus plus sorafenib in treating HCC recurrence after liver transplantation: A case report

doi:10.3748/wjg.v16.i43.5518

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 43

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3074)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series.

Item

Count

PDF

342

HTML

2581

Figures (1-2)

151

Sum=3074

Nov 21, 2010 (publication date) through May 2, 2024

Times Cited of This Article

Times Cited (21)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Nov 21, 2010; 16(43): 5518-5522
Published online Nov 21, 2010. doi: 10.3748/wjg.v16.i43.5518

Full Size Figure Download Figure

Figure 1 Serum α-fetoprotein level measured as related to the treatment history. Serum α-fetoprotein (AFP) level was trending up after sorafenib therapy but normalized after sirolimus was initiated. Events are outlined in the Figure. CT: Computed tomography; HCC: Hepatocellular carcinoma.

Citation: Wang Y, Speeg KV, Washburn WK, Halff G. Sirolimus plus sorafenib in treating HCC recurrence after liver transplantation: A case report. World J Gastroenterol 2010; 16(43): 5518-5522
URL: https://www.wjgnet.com/1007-9327/full/v16/i43/5518.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i43.5518